TITLE

Reduced Expression of p53 and Cyclin A in Intraductal Mucin-Hypersecreting Neoplasm of the Pancreas Compared With Usual Pancreatic Ductal Adenocarcinoma

AUTHOR(S)
Mukawa, Kenji; Kawa, Shigeyuki; Aoki, Yuji; Zhai, Yali; Nikaido, Toshio
PUB. DATE
August 1999
SOURCE
American Journal of Gastroenterology;Aug1999, Vol. 94 Issue 8, p2262
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
OBJECTIVE: Intraductal mucin-hypcrsecreting neoplasm (IMHN) of the pancreas, a slow-growing malignancy with a favorable prognosis, is distinctly categorized from the high-grade malignancy of the more common ductal adenocarcinoma. The aim of the present study was to clarify the molecular differences underlying the biological differences between IMHN and ductal adenocarcinoma of the pancreas. METHODS: The expression of p53 and cyclin A in IMHN was compared with that in ductal adenocarcinoma of the pancreas immunohistochemically. RESULTS: In IMHN, the incidence of p53 and cyclin A ascertained by positive nuclear staining was significantly lower than that in ductal adenocarcinoma. Furthermore, in ductal adenocarcinoma, p53 and cyclin A are topographically coexpressed. CONCLUSIONS: These results suggest that the overexpression of p53 and cyclin A plays a role in the tumorigenesis of pancreatic ductal adenocarcinoma, and sparse expression of both antigens in IMHN may partly contribute to its low-grade malignant characteristics.
ACCESSION #
17830983

 

Related Articles

  • High expression of TROP2 correlates with poor prognosis in pancreatic cancer. Fong, D; Moser, P; Krammel, C; Gostner, J M; Margreiter, R; Mitterer, M; Gastl, G; Spizzo, G // British Journal of Cancer;10/21/2008, Vol. 99 Issue 8, p1290 

    Pancreatic cancer is one of the most devastating human malignancies. Despite considerable research efforts, it remains resistant to almost all available treatment regimens. The human trophoblast cell-surface antigen, TROP2, was found to be strongly expressed in a variety of human epithelial...

  • Characterisation of the progression of azaserine-induced rat pancreatic adenocarcinoma by proliferative cell nuclear antigen, basement membrane laminin and trypsinogen immunohistochemistry. Nagy, Krisztina; Pálfia, Zsolt; Réz, Gábor // Histochemistry & Cell Biology;May2003, Vol. 119 Issue 5, p405 

    The progression of azaserine-induced rat pancreatic adenocarcinoma (AC) was characterised using quantitative and semiquantitative immunohistochemistry for proliferating cell nuclear antigen (PCNA), basement membrane laminin (BML) and trypsinogen (TG). Samples were taken 5–20 months after...

  • Low tube voltage CT for improved detection of pancreatic cancer: detection threshold for small, simulated lesions. Holm, Jon; Loizou, Louiza; Albiin, Nils; Kartalis, Nikolaos; Leidner, Bertil; Sundin, Anders // BMC Medical Imaging;2012, Vol. 12 Issue 1, p20 

    Background: Pancreatic ductal adenocarcinoma is associated with dismal prognosis. The detection of small pancreatic tumors which are still resectable is still a challenging problem. The aim of this study was to investigate the effect of decreasing the tube voltage from 120 to 80 kV on the...

  • Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer. Ino, Y; Yamazaki-Itoh, R; Shimada, K; Iwasaki, M; Kosuge, T; Kanai, Y; Hiraoka, N // British Journal of Cancer;3/5/2013, Vol. 108 Issue 4, p914 

    Background:The host immune reaction is represented by immune/inflammatory cell infiltrates. Here we systematically analysed tumour-infiltrating immune/inflammatory cells in pancreatic ductal carcinoma (PDC) and evaluated their clinicopathological impact.Methods:Using immunohistochemistry, we...

  • High expression of S100A11 in pancreatic adenocarcinoma is an unfavorable prognostic marker. Xiao, Ming-Bing; Jiang, Feng; Ni, Wen-Kai; Chen, Bu-You; Lu, Cui-Hua; Li, Xiao-Yan; Ni, Run-Zhou // Medical Oncology;Sep2012, Vol. 29 Issue 3, p1886 

    S100A11 is a member of S100 protein family, and our previous study showed that S100A11 is one of the up-regulated proteins that have not been reported to be associated with pancreatic carcinoma. The purpose of this study was to investigate the relation between S100A11 expression and the...

  • hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma. Lastraioli, E; Perrone, G; Sette, A; Fiore, A; Crociani, O; Manoli, S; D'Amico, M; Masselli, M; Iorio, J; Callea, M; Borzomati, D; Nappo, G; Bartolozzi, F; Santini, D; Bencini, L; Farsi, M; Boni, L; Di Costanzo, F; Schwab, A; Onetti Muda, A // British Journal of Cancer;3/17/2015, Vol. 112 Issue 6, p1076 

    Background:hERG1 channels are aberrantly expressed in human cancers. The expression, functional role and clinical significance of hERG1 channels in pancreatic ductal adenocarcinoma (PDAC) is lacking.Methods:hERG1 expression was tested in PDAC primary samples assembled as tissue microarray by...

  • Calpain system protein expression in carcinomas of the pancreas, bile duct and ampulla. Storr, Saraj J.; Zaitoun, Abed M.; Arora, Arvind; Durrant, Lindy G.; Lobo, Dileep N.; Madhusudan, Srinivasan; Martin, Stewart G. // BMC Cancer;2012, Vol. 12 Issue 1, p511 

    Background: Pancreatic cancer, including cancer of the ampulla of Vater and bile duct, is very aggressive and has a poor five year survival rate; improved methods of patient stratification are required. Methods: We assessed the expression of calpain-1, calpain-2 and calpastatin in two patient...

  • N-WASP in Pancreatic Ductal Adenocarcinoma: Associations with Perineural Invasion and Poor Prognosis. Guo, Jun-Chao; Li, Jian; Zhao, Yu-Pei; Zhou, Li; Cui, Quan-Cai; Zhou, Wei-Xun; Zhang, Tai-Ping; You, Lei; Shu, Hong // World Journal of Surgery;Aug2014, Vol. 38 Issue 8, p2126 

    Background: Pancreatic ductal adenocarcinoma (PDAC) has long been acknowledged to have a dismal prognosis. Therefore, prognostic markers, especially molecular ones, are of interest. So far, expression of Neural Wiskott-Aldrich syndrome protein (N-WASP) and its associations with clinicopathologic...

  • Loss of heterozygosity predicts poor survival after resection of pancreatic adenocarcinoma. Franko, Jan; Krasinskas, Alyssa M.; Nikiforova, Marina N.; Zarnescu, Narcis O.; Lee, Kenneth K. W.; Hughes, Steven J.; Bartlett, David L.; Zeh III, Herbert J.; Moser, A. James; Zeh, Herbert J 3rd // Journal of Gastrointestinal Surgery;Oct2008, Vol. 12 Issue 10, p1664 

    Background: American Joint Committee on Cancer (AJCC) staging for pancreatic adenocarcinoma is a validated predictor of prognosis but insufficiently discriminates postresection survival. We hypothesized that genetic analysis of resected cancers would correlate with tumor biology and...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics